Abbott Laboratories India

Abbot spinoff AbbVie files to block EU regulator from releasing clinical trials data

11 Mar 2013

US drug maker AbbVie has sued the European drug regulator to prevent it from releasing confidential and commercially-sensitive data of its blockbuster rheumatoid arthritis drug

Abbott introduces bio-absorbable drug eluting vascular scaffold for cardiac use

19 Dec 2012

Abbott to pay $1.6 bn to settle Depakote epilepsy drug suits

09 May 2012

Pleading guilty, Abbott will pay federal and state governments $800 million in civil fines, $700 million in criminal penalties and $100 million to states to resolve consumer offences

Abbott collaborates with Syngene to open first nutrition research centre in India

05 May 2012

Abbott to pay $1.3 bn to settle Depakote epilepsy drug claims

24 Oct 2011

The settlement is an outcome of a whistle-blower lawsuit bought on by former and current Abbott sales employees alleging unapproved uses were promoted in a variety of US healthcare programs.

Abott to split into two

19 Oct 2011

Lupin signs agreement with Abott Laboratories and others for Fenofibrate

27 Apr 2011

India rejects HIV drug patent application by Abbott Laboratories

03 Jan 2011

Solvay Pharma to merge with Abbott India in a 3:2 share swap

25 Nov 2010

Abbott recalls 5 million infant formulas over beetle larvae contamination

23 Sep 2010

Abbott to keep Piramal business separate after acquisition

11 Sep 2010

Abbott to hive off flu vaccine business of Solvay: report

29 Jun 2010

Abbott signs $575 million endometriosis drug deal with Neurocrine

16 Jun 2010

Abbott is India's biggest pharma firm after $3.7-bn Piramal deal

21 May 2010

Abbott plans to fund the transaction with its own cash reserves and says that the acquisition will not impact its ongoing earnings per share guidance in 2010

Abbott signs agreement to market 24 Zydus Cadila products

12 May 2010

Abbott completes acquisition of Starlims Technologies

23 Mar 2010

Abbott receives US FDA approval for new cataract multifocal intraocular lens

11 Mar 2010

Abbott Laboratories to acquire Facet Biotech for $450 million

10 Mar 2010

Abbott bids for 20 per cent of Solvay India

17 Feb 2010

Bombay HC rejects plea to block Wockhardt deal with Abbott

18 Jan 2010

Abbott to acquire Starlims Technologies for $123 million

15 Dec 2009

Abbott to acquire Belgian drug company Solvay for $6.6 billion

29 Sep 2009

In a year of consolidation of the global pharmaceutical industry, Abbott Laboratories plans to acquire Solvay's pharmaceutical business for $6.6

Abbott expands vision care portfolio; buys Visiogen

03 Sep 2009

Wockhardt sells its nutrition businesses to Abbott for $130 million

28 Jul 2009

Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks

05 Dec 2007